Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 19:39:58 +0200Mon, 13 May 2024 12:04:00 +0200Human medicines European public assessment report (EPAR): Heplisav B, hepatitis B surface antigen, Date of authorisation: 18/02/2021, Revision: 6, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/heplisav-bHuman medicines European public assessment report (EPAR): Heplisav B, hepatitis B surface antigen, Date of authorisation: 18/02/2021, Revision: 6, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/heplisav-bMon, 13 May 2024 12:04:00 +0200Human medicineHeplisav B : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5063-en.pdfHeplisav B : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5063-en.pdfMon, 13 May 2024 09:07:00 +0200Human medicine